Integrative Analysis of Genetic and Epigenetic Alterations in the CBX7 Gene Reveals Its Tumor-Suppressive Function by Regulating the Cell Cycle in Human Breast Cancer

Supplementary Files

Supplementary Material


Breast cancer
genetic alteration
epigenetic alteration
gene co-expression

How to Cite

Cai, Y., Chang, H., Perez-Losada, J., & Mao, J.-H. (2023). Integrative Analysis of Genetic and Epigenetic Alterations in the CBX7 Gene Reveals Its Tumor-Suppressive Function by Regulating the Cell Cycle in Human Breast Cancer. Oncology Insights.


CBX7 is a member of the chromobox gene family, which plays an important role in epigenetic transcriptional regulation. In this study, we found that compared to normal mammary tissues, mRNA levels of CBX7 are consistently significantly downregulated in breast cancers (BCs) across different datasets. Integrative multiomics analysis revealed the genetic and epigenetic mechanisms for the loss of CBX7 expression in BCs. Lower expression levels of CBX7 are significantly associated with shorter overall, disease-free, and distant metastasis-free survival of patients with BC. These prognostic impacts of CBX7 are independent of estrogen receptor status and PAM50 molecular subtypes. Coexpression analysis identified 207 genes consistently coexpressed with CBX7 (157 negatively and 50 positively). Gene Ontology, KEGG, and Reactome enrichment analysis revealed that cell cycle‑, DNA replication‑, and mitosis-related pathways are significantly overrepresented within the set of CBX7 negatively coexpressed genes, suggesting that CBX7 functions as a suppressor of the cell cycle. Moreover, transcription factor enrichment analysis detected the E2F family of transcription factors significantly associated with CBX7 negatively coexpressed genes, consistent with E2F function regulating the cell cycle. Furthermore, we found that loss of CBX7 expression significantly increases genomic instability and tumor mutation burden. Our findings indicate that CBX7 acts as a tumor suppressor in BC through its potential role in the negative regulation of cell proliferation and the maintenance of genome integrity.


Giaquinto AN, Miller KD, Tossas KY, Winn RA, Jemal A, Siegel RL. Breast Cancer Statistics. CA Cancer J Clin. 2022 May;72(3):202-229.

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022 Jan;72(1):7-33.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249.

Cancer Genome Atlas, N., Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 4;490(7418):61-70.

Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012 Apr 18;486(7403):346-52.

Pereira B, Chin SF, Rueda OM, Vollan HK, Provenzano E, Bardwell HA, et al., The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016 May 10;7:11479.

Sanchez-Vega F, Mina M, Armenia J, Chatila WK, Luna A, La KC, et al. Oncogenic Signaling Pathways in The Cancer Genome Atlas. Cell, 2018. 173(2): 321-337 e10.

Cheng Y, He C, Wang M, Ma X, Mo F, Yang S, et al. Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials. Signal Transduct Target Ther, 2019. 4: 62.

Ilango S, Paital B, Jayachandran P, Padma PR, Nirmaladevi R. Epigenetic alterations in cancer. Front Biosci (Landmark Ed). 2020 Mar 1;25(6):1058-1109.

Wang M, Sunkel BD, Ray WC, Stanton BZ. Chromatin structure in cancer. BMC Mol Cell Biol, 2022. 23(1): 35.

Baylin SB, Jones PA. Epigenetic Determinants of Cancer. Cold Spring Harb Perspect Biol. 2016 Sep 1;8(9):a019505.

Gil J, O'Loghlen A. PRC1 complex diversity: where is it taking us? Trends Cell Biol. 2014 Nov;24(11):632-41.

Kim J, Kingston RE. The CBX family of proteins in transcriptional repression and memory. J Biosci. 2020;45:16.

Hu CY, Li X, Zeng T, Ye DM, Li YK, Yan HX. Significance of chromobox protein (CBX) expression in diffuse LBCL. Gene. 2022 Mar 1;813:146092.

Hu K, Yao L, Xu Z, Yan Y, Li J. Prognostic Value and Therapeutic Potential of CBX Family Members in Ovarian Cancer. Front Cell Dev Biol, 2022; 10: 832354.

Hu K, Yao L, Zhou L, Li J. Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma. Int J Gen Med. 2022 Mar 4;15:2463-2474.

Li D, Liu Y, Hao S, Chen B, Li A. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma. J Clin Lab Anal. 2020 Dec;34(12):e23537.

Mao G, Zheng Y, Lin S, Ma L, Zhou Z, Zhang S. Bioinformatic Analysis of Prognostic Value, Genetic Interaction, and Immune Infiltration of Chromobox Family Proteins in Breast Cancer. Int J Gen Med. 2021 Dec 1;14:9181-9191.

Naqvi AAT, Rizvi SAM, Hassan MI. Pan-cancer analysis of Chromobox (CBX) genes for prognostic significance and cancer classification. Biochim Biophys Acta Mol Basis Dis. 2023 Jan 1;1869(1):166561.

Zhang C, Chang L, Yao Y, Chao C, Ge Z, Fan C, et al. Role of the CBX Molecular Family in Lung Adenocarcinoma Tumorigenesis and Immune Infiltration. Front Genet. 2021 Dec 13;12:771062.

Zhang YJ, Zhao LY, He X, Yao RF, Lu F, Lu BN, et al. CBXs-related prognostic gene signature correlates with immune microenvironment in gastric cancer. Aging (Albany NY). 2022 Aug 14;14(15):6227-6254.

Zheng ZQ, Yuan GQ, Kang NL, Nie QQ, Zhang GG, Wang Z. Chromobox 7/8 serve as independent indicators for glioblastoma via promoting proliferation and invasion of glioma cells. Front Neurol. 2022 Aug 11;13:912039.

Fan Y, Li H, Liang X, Xiang Z. CBX3 promotes colon cancer cell proliferation by CDK6 kinase-independent function during cell cycle. Oncotarget. 2017 Mar 21;8(12):19934-19946.

He Z, Chen J, Chen X, Wang H, Tang L, Han C. microRNA-377 acts as a suppressor in esophageal squamous cell carcinoma through CBX3-dependent P53/P21 pathway. J Cell Physiol. 2021 Jan;236(1):107-120.

Zhang H, Chen W, Fu X, Su X, Yang A. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma. Gene. 2018 May 15;654:49-56.

Forzati F, Federico A, Pallante P, Abbate A, Esposito F, Malapelle U, et al., CBX7 is a tumor suppressor in mice and humans. J Clin Invest, 2012. 122(2): p. 612-23.

Li X, Gou J, Li H, Yang X. Bioinformatic analysis of the expression and prognostic value of chromobox family proteins in human breast cancer. Sci Rep. 2020 Oct 20;10(1):17739.

Liang YK, Lin HY, Chen CF, Zeng D. Prognostic values of distinct CBX family members in breast cancer. Oncotarget, 2017. 8(54): p. 92375-92387.

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al., The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012 May;2(5):401-4.

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al, Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1.

Bartha Á, Győrffy B. A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int J Mol Sci. 2021 Mar 5;22(5):2622.

Li Y, Ge D, Lu C. The SMART App: an interactive web application for comprehensive DNA methylation analysis and visualization. Epigenetics Chromatin. 2019 Dec 5;12(1):71.

Jézéquel P, Campone M, Gouraud W, Guérin-Charbonnel C, Leux C, Ricolleau G, et al. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer. Breast Cancer Res Treat. 2012 Feb;131(3):765-75.

Liao Y, Wang J, Jaehnig EJ, Shi Z, Zhang B. WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs. Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. DOI: 10.1093/nar/gkz401

Iqbal MA, Siddiqui S, Ur Rehman A, Siddiqui FA, Singh P, Kumar B, et al. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in metabolic reprogramming of breast cancer. Mol Oncol. 2021 May;15(5):1450-1465.

Federico A, Pallante P, Bianco M, Ferraro A, Esposito F, Monti M, et al., Chromobox protein homologue 7 protein, with decreased expression in human carcinomas, positively regulates E-cadherin expression by interacting with the histone deacetylase 2 protein. Cancer Res. 2009 Sep 1;69(17):7079-87.

Dai T, Liu Y, Cao R, Cao J. CBX7 regulates metastasis of basal-like breast cancer through Twist1/EphA2 pathway. Transl Oncol. 2022 Oct;24:101468.

Lammens T, Li J, Leone G, De Veylder L. Atypical E2Fs: new players in the E2F transcription factor family. Trends Cell Biol. 2009 Mar;19(3):111-8.

Cho KW, Andrade M, Zhang Y, Yoon YS. Mammalian CBX7 isoforms p36 and p22 exhibit differential responses to serum, varying functions for proliferation, and distinct subcellular localization. Sci Rep, 2020. 10(1): p. 8061.

Li J, Ouyang T, Li M, Hong T, Alriashy M, Meng W, et al. CBX7 is Dualistic in Cancer Progression Based on its Function and Molecular Interactions. Front Genet. 2021 Oct 1;12:740794.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2023 Cai Y et al.